NCT04420052

Brief Summary

Chronic Rhinosinusitis (CRS) is a chronic condition with limited therapeutic options. Moreover, the pathophysiology is poorly understood. The aim of this study is to evaluate the efficacy of osteopathic manipulative treatment (OMT) in the course of this condition by applying several techniques supposed to be related to the autonomic nervous system. Our hypothesis is that these techniques could have beneficial effects on inflammation and head symptoms in CRS. Methods: A sample of 90 patients diagnosed by ENT specialist will be randomly assigned to the OMT group or the placebo group. The placebo procedure will consist in using light touch around the nose, on the throat and on the thorax. Treatment and placebo protocols are composed of two visits at day 0 and day 30. A general practitioner will determine the eligibility for the study. The outcomes include Peak Nasal Inspiratory Flow (PNIF) measured five times: at day 0, 30 (twice each, before and after treatment) and 180 (once). The two groups will be compared regarding short and long term evolution. The evolution of symptoms will be assessed by the Sino-nasal Outcome Test (SNOT-22) seven times: at day 0, 30, 60, 90, 120, 150 and 180. This outcome will be analyzed using mixed effect modelling A Qualitative study will be conducted in the two groups to understand the patients' experiences during care. This protocol has been approved by a french ethic committee (Comité de Protection des Personnes Sud Ouest et Outre-Mer II, 2020.04.09).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

11 months

First QC Date

May 28, 2020

Last Update Submit

July 29, 2023

Conditions

Keywords

Osteopathic manipulative treatmentNon-allergicrhinosinusitisChronic Diseaserhinitissinusitismanual therapyosteopathylight touch

Outcome Measures

Primary Outcomes (1)

  • Change in peak nasal inspiratory flow (PNIF)

    The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask.

    PNIF will be perform at day 0 (before treatment) and at day 30 (before treatment)

Secondary Outcomes (4)

  • Change in Sino-nasal Outcomes Test 22 (SNOT-22)

    Patients will complete the questionnaire at baseline (day 0), day 30, day 60, day 90, day 120, day 150 and day 180 to assess the change over time

  • Patient-reported experience of care

    Interview will occur at day 180

  • Sort term change in peak nasal inspiratory flow (PNIF)

    PNIF will be perform at day 0 (before and after treatment), day 30 (before and after treatment)

  • long term change in peak nasal inspiratory flow (PNIF)

    PNIF will be perform at day 0 (before treatment) and at day 180.

Study Arms (2)

OMT group

EXPERIMENTAL
Other: Osteopathic manipulative treatment

Placebo group

PLACEBO COMPARATOR
Other: Placebo manipulation

Interventions

Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis. This procedure takes around 15 minutes.

OMT group

The osteopath will lay hands without movement on the nose, the throat and the thorax of patients. This procedure takes around 15 minutes.

Placebo group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age between 18 and 50
  • Chronic rhinosinusitis diagnosed by ear, nose, and throat (ENT) specialist or general practitioner
  • informed consent given
  • registered under french social security system

You may not qualify if:

  • contraindication to spine manipulation
  • receiving other treatment for CRS during this study
  • being pregnant
  • being under legal protection
  • withdrawal of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cabinet ORL du Maine

Le Mans, 72000, France

Location

MeSH Terms

Conditions

RhinosinusitisChronic DiseaseRhinitisSinusitis

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • sebastien cambier

    Institut des Hautes Etudes Osteopathiques de Nantes

    PRINCIPAL INVESTIGATOR
  • maxime salmon, MsC

    Institut des Hautes Etudes Osteopathiques de Nantes

    STUDY DIRECTOR
  • Marie Moreau

    Institut des Hautes Etudes Osteopathiques de Nantes

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The care provider knows the assignment of patient. In order to know if the blinding was effective, at the end of each treatment, patient will have to tell if they were in the placebo or the OMT group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 9, 2020

Study Start

July 1, 2021

Primary Completion

June 1, 2022

Study Completion

June 30, 2022

Last Updated

August 1, 2023

Record last verified: 2023-07

Locations